Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score

The Oncotype DX(®) recurrence score (RS) predictor has been clinically utilized to appropriately select adjuvant chemotherapy for patients with estrogen receptor (ER)-positive early breast cancer. However, the selection of chemotherapy for patients with intermediate RSs remains controversial. We ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Sung Gwe, Lee, Hak Min, Lee, Hak Woo, Lee, Seung Ah, Lee, Se-Ra, Leem, Sun-Hee, Jeong, Joon, Chu, In-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876071/
https://www.ncbi.nlm.nih.gov/pubmed/24304542
http://dx.doi.org/10.3390/ijms141223685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876071/
https://www.ncbi.nlm.nih.gov/pubmed/24304542
http://dx.doi.org/10.3390/ijms141223685

Ejemplares similares